Businesses rise and fall with the success of their research and development (R&D). But although the intellectual property that R&D creates will often generate valuable cash flow, it is seldom recognised on the balance sheet.

That can now change, as IPA has developed a revolutionary new way to capitalise your IP through its unique Digital Novel Assets (DNA). Backed by the FRS102 accounting standard, our DNA can help you unlock new value for your business.

Through copyright, the confidential timestamped documents our process creates can be protected longer than patents, without exposing to the world the precise nature of your innovations.